M&A - TELEFLEX INC

Form Type: 8-K

Filing Date: 2025-06-30

Corporate Action: Acquisition

Type: New

Accession Number: 000009694325000107

Filing Summary: On June 24, 2025, Teleflex Incorporated entered into an amendment to its Third Amended and Restated Credit Agreement. This amendment provides for additional delayed draw term loan commitments totaling $200,000,000. With these additional commitments, the total available under the Delayed Draw Term Loan Facility is now $700,000,000. The funds will be available upon consummation of Teleflex's acquisition of the Vascular Intervention business segment of MS Holding II SE, subject to customary conditions. The terms of the Delayed Draw Term Loan Facility were otherwise unchanged from those described in a previous filing on February 27, 2025. Forward-looking statements contained within the report address risks and uncertainties related to the pending acquisition and amendment details.